Professional Documents
Culture Documents
ÇÇ îÂÏ °Á ºÏ ÇÓÃÌÇÆ ÖÊ ËØÖÎÁÆ Äó ÐÔ ÇÑ× °Ñ ÜÔË ÐÔ ÇÑ×Ð Û Û Ì
ÇÇ îÂÏ °Á ºÏ ÇÓÃÌÇÆ ÖÊ ËØÖÎÁÆ Äó ÐÔ ÇÑ× °Ñ ÜÔË ÐÔ ÇÑ×Ð Û Û Ì
ÇÇ îÂÏ °Á ºÏ ÇÓÃÌÇÆ ÖÊ ËØÖÎÁÆ Äó ÐÔ ÇÑ× °Ñ ÜÔË ÐÔ ÇÑ×Ð Û Û Ì
doi:10.6040/j.issn.1673-3770.0.2018.620 • 论著 •
鼻腔盥洗及联合鼻用糖皮质激素治疗变应性鼻炎及血管运动性
鼻炎效果观察
孙铭宏,高娴,赵婷,刘文君
(青岛市立医院耳鼻喉科,山东 青岛 266071)
引用格式:孙铭宏,高娴,赵婷,等 . 鼻腔盥洗及联合鼻用糖皮质激素治疗变应性鼻炎及血管运动性鼻炎效果观察
[J]. 山东大学耳鼻喉眼学报,2019,33(5):73-78.SUN Minghong, GAO Xian, ZHAO Ting, et al. Comparison between
the efficacy of nasal lavage and combination treatment in allergic rhinitis and vasomotor rhinitis[J]. J Otolaryngol
Ophthalmol Shandong Univ, 2019, 33(5):73-78.
Comparison between the efficacy of nasal lavage and combination treatment in allergic rhinitis and vasomotor rhinitis
SUN Minghong,GAO Xian,ZHAO Ting,LIU Wenjun
Department of Otolaryngology,Qingdao Municipal Hospital,Qingdao 266071,Shandong,China
Abstract: Objective The aim of this study was to compare the efficacy of nasal lavage alone and nasal lavage in combination
with nasal corticosteroids in allergic rhinitis(AR)and vasomotor rhinitis(VMR). Methods This study included 93 patients with
AR and 56 patients with VMR,who were randomly divided into three groups each:A1,A2,and A3(n = 31 in each group)and
V1(n = 19)
,V2(n = 17)
,and V3(n = 20)
,respectively. Patients in groups A1 and V1,A2 and V2,and A3 and V3 were treated
with budesonide nasal spray,nasal flushing with 0.9% sodium chloride solution,and a combination of nasal lavage and budesonide
nasal spray,respectively,for three months each. Nasal symptoms were assessed using the visual analog scale(VAS)before and af⁃
ter the intervention;the rhinoconjunctivitis quality of life questionnaire(RQLQ)was used to evaluate the quality of life, and the
fractional exhaled nitric oxide(FENO)values were measured by the exhaled NO assay system.. Results All patients completed
the experiment with good tolerance, and no serious adverse reactions occurred. The VAS, RQLQ, and FENO values in the A3
group after three months were significantly lower than the values before intervention. There was no statistically significant differ⁃
ence in the total VAS scores among the A1,A2 and A3 groups(F = 1.465,P = 0.174). There were statistically significant differ⁃
ences in the total RQLQ scores between the A3 and A1 groups(t = 2.668,P = 0.014)
,but not between the A2 and A3 groups(t =
1.545,P = 0.136). There were statistically significant differences in the FENO values between the A3 and A1 groups(t= 3.241,P=
0.004)and between the A3 and A2 groups(t= 2.987,P = 0.008). At the end of the third month of treatment, VAS,RQLQ,and
FENO values in the V3 group were significantly lower than the values before intervention. The differences in total VAS scores were
收稿日期:2018⁃12⁃24;修回日期:2019⁃03⁃26
通信作者:刘文君。E-mail:13605329939@163.com
山东大学耳鼻喉眼学报 2019 年 10 月 第 33 卷 第 5 期
·74 · J Otolaryngol Ophthalmol Shandong Univ, Vol.33 , No.5, 2019
statistically significant between the V3 and V1 groups(t = 2.352,P = 0.027)and between the V3 and V2 groups(t = 2.083,P =
0.043). There were statistically significant differences in RQLQ scores between the V3 and V1 groups(t = 2.581,P=0.013)and be⁃
tween the V3 and V2 groups(t = 2.339,P = 0.031). There was no significant difference in the FENO values among the V1,V2
and V3 groups(F=1.563, P=0.159). Conclusion Nasal lavage alone or nasal lavage in combination with glucocorticoids was
more efficient in the long-term treatment of AR and VMR.
Key words:Rhinitis,allergic;Rhinitis,vasomotor;Nasal irrigation;Treatment outcome
-
表 5 VMR 患者干预 1、2、3 个月后与干预前 RQLQ 总分比较(x±s,分)
Table 5 Comparison between rhinoconjunctivitis quality of life questionnaire(RQLQ)scores of vasomotor rhinitis(VMR)pa⁃
-
tients before and after intervention( x±s )
RQLQ 总分
组别
治疗前 1 个月末 2 个月末 3 个月末
V1 组 59.14±21.49 42.56±20.14 45.32±17.63 47.05±19.87
V2 组 57.65±17.68 48.26±16.83 40.75±18.37 38.65±16.79
V3 组 56.31±27.74 40.27±18.67 36.36±19.83 29.25±15.20
t1 2.454 a
2.167 a
1.801b
t2 1.586 b 2.733a 3.213a
t3 2.145 a 2.617 a 3.826 a
注:t1 值为 V1 组干预第 1、2、3 个月末与干预前比较;t2 值为 V2 组干预第 1、2、3 个月末与干预前比较;t3 值为 V3 组干预第 1、
2、3 个月末与干预前比较;a 为 P<0.05,b 为 P>0.05。